YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Apheresis in Patients With Sepsis: a Multicenter Retrospective Study

dc.authorid Kuku, Irfan/0000-0001-6126-0816
dc.authorid Eser, Bulent/0000-0002-4513-3486
dc.authorid Aydin, Kaniye/0000-0001-5538-3692
dc.authorscopusid 57219605249
dc.authorscopusid 14022986200
dc.authorscopusid 8842895600
dc.authorscopusid 57217226603
dc.authorscopusid 57194114271
dc.authorscopusid 54415337500
dc.authorscopusid 6603662687
dc.authorwosid Altuntas, Fevzi/E-8945-2015
dc.authorwosid Erkurt, Mehmet/Abi-7232-2020
dc.authorwosid Sarici, Ahmet/Abi-7512-2020
dc.authorwosid Ulas, Turgay/A-6050-2018
dc.authorwosid Doğan, Mehmet/A-6890-2015
dc.authorwosid Berber, Ilhami/Abi-6231-2020
dc.authorwosid Aydin, Kaniye/Krq-6358-2024
dc.contributor.author Aydin, Kaniye
dc.contributor.author Korkmaz, Serdal
dc.contributor.author Erkurt, Mehmet Ali
dc.contributor.author Sarici, Ahmet
dc.contributor.author Ekinci, Omer
dc.contributor.author Baysal, Nuran Ahu
dc.contributor.author Altuntas, Fevzi
dc.date.accessioned 2025-05-10T17:14:10Z
dc.date.available 2025-05-10T17:14:10Z
dc.date.issued 2021
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Aydin, Kaniye] Univ Hlth Sci, Kayseri City Training & Res Hosp, Dept Internal Med, Med Intens Care Unit, Kayseri, Turkey; [Korkmaz, Serdal] Univ Hlth Sci, Kayseri City Training & Res Hosp, Dept Hematol, Kayseri, Turkey; [Korkmaz, Serdal; Dogan, Ali; Ozatli, Duzgun] Apheresis Unit, Kayseri, Turkey; [Erkurt, Mehmet Ali; Sarici, Ahmet; Berber, Ilhami; Kuku, Irfan] Inonu Univ, Dept Hematol, Malatya, Turkey; [Ekinci, Omer] Univ Hlth Sci, Gazi Yasargil Training & Res Hosp, Dept Hematol, Diyarbakir, Turkey; [Baysal, Nuran Ahu; Dal, Mehmet Sinan; Altuntas, Fevzi] Univ Hlth Sci, Ankara Oncol Training & Res Hosp, Dept Hematol, Ankara, Turkey; [Dogan, Ali; Ozatli, Duzgun] Yuzuncu Yil Univ, Dept Hematol, Van, Turkey; [Giden, Asli Odabasi] Ondokuz Mayis Univ, Dept Hematol, Samsun, Turkey; [Ulas, Turgay] Near East Univ, Sch Med, Dept Internal Med, Div Hematol, Nicosia, Cyprus; [Eser, Bulent] Med Pk Antalya Hosp, Dept Hematol, Antalya, Turkey; [Altuntas, Fevzi] Ankara Yildirim Beyazit Univ, Sch Med, Dept Internal Med, Div Hematol, Ankara, Turkey en_US
dc.description Kuku, Irfan/0000-0001-6126-0816; Eser, Bulent/0000-0002-4513-3486; Aydin, Kaniye/0000-0001-5538-3692 en_US
dc.description.abstract Background and objectives: To consider the effectiveness of apheresis, which is a supportive treatment method, in sepsis. Materials and methods: A hundred and eleven adults with sepsis or septic shock were included in this retrospective study. The demographic characteristics of the patients, the focus and source of infection causing sepsis or septic shock, characteristics of the pathogen, Acute Physiological and Chronic Health Assessment (APACHE) II score, routine laboratory values, which apheresis method was used, the characteristics of the replacement fluids used during the apheresis procedure, the number of apheresis procedures, complications related to the apheresis procedure, the follow-up time after the procedure, and mortality were recorded. The primary outcome was 28day mortality. Results: Sixty-nine (62.2 %) of the patients were male. The mean age of the patients was 47.7 +/- 18.6 years. The most common source of sepsis was hospital-acquired (79.3 %), the most common pathogen causing sepsis was gram-negative bacteria (41.4 %), and the most common infection site was the respiratory tract (58.7 %). The median APACHE II score was 19 (13-24). 92 (82.9 %) of the patients had septic shock. Theropeutic plasma exchange (TPE) was performed in 11.7 % of the patients and immunoabsorbtion IA in 88.3 %. The median number of sessions was 3 (3-5). No procedure-related fatal complication was observed in the study. While 28day mortality was 61.3 % in all patients, when the mortality according to the apheresis procedures was examined, it was 11.3 % and 88.2 % in the patients who underwent TPE and IA, respectively. The most common cause of mortality was multiorgan failure. Conclusions: Apheresis in sepsis can be considered as a salvage treatment. The indication for apheresis in sepsis is still at the level of patient-based individualized decision in line with the studies done so far, including our study. However, there is a need for a multicenter randomized controlled study with a large number of patients in order to give positive or negative recommendations about its effectiveness. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1016/j.transci.2021.103239
dc.identifier.issn 1473-0502
dc.identifier.issn 1878-1683
dc.identifier.issue 5 en_US
dc.identifier.pmid 34412948
dc.identifier.scopus 2-s2.0-85112745524
dc.identifier.scopusquality Q3
dc.identifier.uri https://doi.org/10.1016/j.transci.2021.103239
dc.identifier.uri https://hdl.handle.net/20.500.14720/8414
dc.identifier.volume 60 en_US
dc.identifier.wos WOS:000697004600019
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Pergamon-elsevier Science Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Sepsis en_US
dc.subject Multiorgan Failure en_US
dc.subject Apheresis en_US
dc.subject Therapeutic Plasma Exchange en_US
dc.subject Immunadsorption en_US
dc.subject Mortality en_US
dc.title Apheresis in Patients With Sepsis: a Multicenter Retrospective Study en_US
dc.type Article en_US

Files